Company: NMP
Filing Date: 2025-07-07
Form Type: 8-K
Source: 0001213900-25-061598
Chunk: 4

Company: NMP Acquisition Corp.
Filing Date: 2025-07-07
Form: 8-K
Item: Item 3.02
Chunk 4
---
 was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective upon the commencement of trading of the Units on The Nasdaq
Global Market (“ Nasdaq”) on July 1, 2025, Adam Benson, Shanti Priya
and Dr. Vanila M. Singh became members of the Company’s board of directors (the “ Board”).

The Board has determined that
each of Mr. Benson, Ms. Priya and Dr. Singh are independent directors under Nasdaq’s listing standards and under the Securities
Exchange Act of 1934, as amended (the “ Exchange Act”), and that Ms. Priya qualifies as an “audit committee financial
expert” as that term is defined in Item 407(d)(5) of Regulation S-K under the Exchange Act. Mr. Benson, Ms. Priya and Dr. Singh
will each serve as members of the audit committee, nominating committee and compensation committee of the Board, with Ms. Priya serving
as chair of the audit committee, Dr. Singh serving as chair of the nominating committee and Mr. Benson as chair of the compensation committee.

Prior to the Company’s
consummation of its IPO, the Sponsor transferred non-managing membership interests to each of Mr. Benson, Ms. Priya and Dr. Singh representing
interests in an aggregate of 150,000 founder shares, or 50,000 shares each, as compensation for their services as directors.

In
connection with their appointments to the Board, each of the members of the Board entered into the Letter Agreement as well as an Indemnity
Agreement with the Company filed, respectively, as Exhibits 10.1 and 10.7, herewith.

Other than as set forth in
Item 1.01 and above, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointed
as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.

Item 5.03. Amendments
to Certificate of Incorporation or Bylaws; Change in Fiscal Year

In
connection with the IPO, the Company adopted its Amended Charter on June 30, 2025. The terms of the Amended Charter are set